Advisornet Financial’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $137K | Buy |
219
+84
| +62% | +$57.2K | 0.01% | 760 |
|
|
2026
Q1 | $104K | Buy |
135
+83
| +160% | +$63.5K | 0.01% | 812 |
|
|
2025
Q4 | $40.2K | Sell |
52
-10
| -16% | -$6.79K | ﹤0.01% | 1116 |
|
|
2025
Q3 | $34.9K | Buy |
62
+1
| +2% | +$565 | ﹤0.01% | 1140 |
|
|
2025
Q2 | $32.1K | Sell |
61
-14
| -19% | -$7.81K | ﹤0.01% | 1133 |
|
|
2025
Q1 | $47.6K | Sell |
75
-3
| -4% | -$2.06K | ﹤0.01% | 954 |
|
|
2024
Q4 | $55.6K | Sell |
78
-22
| -22% | -$18.5K | ﹤0.01% | 851 |
|
|
2024
Q3 | $105K | Buy |
100
+31
| +45% | +$34.5K | 0.01% | 688 |
|
|
2024
Q2 | $72.5K | Hold |
69
| – | – | 0.01% | 712 |
|
|
2024
Q1 | $66.4K | Sell |
69
-34
| -33% | -$32.3K | 0.01% | 737 |
|
|
2023
Q4 | $90.5K | Sell |
103
-20
| -16% | -$16.5K | 0.01% | 671 |
|
|
2023
Q3 | $101K | Sell |
123
-121
| -50% | -$95.1K | 0.01% | 610 |
|
|
2023
Q2 | $175K | Sell |
244
-12
| -5% | -$9.25K | 0.02% | 507 |
|
|
2023
Q1 | $210K | Buy |
256
+1
| +0.4% | +$754 | 0.02% | 454 |
|
|
2022
Q4 | $184K | Buy |
255
+21
| +9% | +$15.5K | 0.02% | 488 |
|
|
2022
Q3 | $161K | Sell |
234
-5
| -2% | -$3.15K | 0.02% | 548 |
|
|
2022
Q2 | $141K | Buy |
239
+122
| +104% | +$79.3K | 0.01% | 578 |
|
|
2022
Q1 | $82K | Sell |
117
-13
| -10% | -$8.22K | 0.01% | 809 |
|
|
2021
Q4 | $82K | Buy |
130
+2
| +2% | +$1.23K | 0.01% | 874 |
|
|
2021
Q3 | $77K | Buy |
128
+1
| +0.8% | +$621 | 0.01% | 874 |
|
|
2021
Q2 | $71K | Sell |
127
-17
| -12% | -$8.61K | ﹤0.01% | 884 |
|
|
2021
Q1 | $68K | Sell |
144
-16
| -10% | -$7.79K | ﹤0.01% | 862 |
|
|
2020
Q4 | $77K | Sell |
160
-41
| -20% | -$22.1K | 0.01% | 764 |
|
|
2020
Q3 | $113K | Buy |
201
+25
| +14% | +$15.2K | 0.01% | 638 |
|
|
2020
Q2 | $110K | Buy |
176
+75
| +74% | +$42.6K | 0.01% | 644 |
|
|
2020
Q1 | $49K | Buy |
101
+21
| +26% | +$8.66K | ﹤0.01% | 797 |
|
|
2019
Q4 | $30K | Hold |
80
| – | – | ﹤0.01% | 1060 |
|
|
2019
Q3 | $22K | Sell |
80
-1
| -1% | -$296 | ﹤0.01% | 1165 |
|
|
2019
Q2 | $25K | Buy |
81
+4
| +5% | +$1.33K | ﹤0.01% | 1003 |
|
|
2019
Q1 | $32K | Hold |
77
| – | – | ﹤0.01% | 872 |
|
|
2018
Q4 | $29K | Buy |
77
+52
| +208% | +$19K | ﹤0.01% | 827 |
|
|
2018
Q3 | $10K | Hold |
25
| – | – | ﹤0.01% | 1118 |
|
|
2018
Q2 | $9K | Hold |
25
| – | – | ﹤0.01% | 1173 |
|
|
2018
Q1 | $9K | Hold |
25
| – | – | ﹤0.01% | 1124 |
|
|
2017
Q4 | $9K | Buy |
+25
| New | +$10.1K | ﹤0.01% | 1030 |
|
Other funds holding REGN
GA
WCM
AIP
AP
Advisornet Financial's REGN Position: Q2 2026 in Review
Advisornet Financial increased its Regeneron Pharmaceuticals (REGN) stake by 62% in Q2 2026, buying an estimated $57.2K and bringing the position to 219 shares worth $137K. The position accounts for 0.01% of the portfolio, ranked #760.
Advisornet Financial first reported a position in REGN in Q4 2017 and has held it in 35 quarters since. The position peaked at $210K in Q1 2023. 315 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Advisornet Financial held 219 shares of Regeneron Pharmaceuticals worth $137K as of Q2 2026.
- Advisornet Financial bought 84 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $57.2K.
- Regeneron Pharmaceuticals made up 0.01% of Advisornet Financial's portfolio in Q2 2026, its #760 holding.
- Advisornet Financial first reported a position in Regeneron Pharmaceuticals in Q4 2017 and has held it in 35 quarters since.
- Advisornet Financial's Regeneron Pharmaceuticals position peaked at $210K in Q1 2023.
- 315 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.